ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Comparative and Clinical Medicine
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1520917
This article is part of the Research TopicInnovative Approaches in Veterinary Pathology: Diagnostics, Therapeutics, and Zoonotic ThreatsView all 8 articles
Reduced Glomerular and Elevated Tubulointerstitial Transglutaminase pathway and its inhibition in a Rat Model of Renal Warm Ischemia: Implications for Feline Chronic Kidney Disease
Provisionally accepted- 1Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, Cambridge, England, United Kingdom
- 2Department of Chemical and Biological Engineering, Faculty of Engineering, The University of Sheffield, Sheffield, England, United Kingdom
- 3Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, England, United Kingdom
- 4University of Central Lancashire, Preston, England, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Feline CKD is associated with an increase in the pro-fibrotic enzyme, transglutaminase 2 (TG2), in the kidney tubulointerstitium. Hypoxia is pivotal factor for the development of CKD, irrespective of its origin. In cats, tubulointerstitial sclerosis develops without significant glomerular involvement, similar to a rodent model of renal warm ischaemia (RWI).Methods: Sprague-Dawley rats underwent 60-minutes renal hilar clamping followed by right nephrectomy with/without intrarenal infusion of a transglutaminase inhibitor (TGI). Renal fibrosis was assessed by immunofluorescence of collagens after 28-days. Extracellular-TG-enzyme activity (eTGact) and extracellular-TG2 protein (eTG2) were measured in both the glomerular and the tubulointerstitial spaces. Hypothesis: Renal Warm Ischemia (RWI) will induce fibrotic changes and activation of the transglutaminase pathway in both the tubulointerstitial and glomerular compartments, and that treatment with a transglutaminase inhibitor (TGI) will mitigate these effects.Results: Rats subjected to RWI showed a significant elevation in tubulointerstitial collagen I (1.8-fold), III (4.3-fold), IV (5.5-fold), eTGact (2-fold) and eTG2 (1.9-fold), together with an increase in serum creatinine (2.7-fold). TG inhibition significantly reduced tubulointerstitial collagen I, III, IV, eTGact and eTG2 by 100%, 57%, 90%, 89% and 91%, respectively, and decreased creatinine levels by 70%. However, RWI in the glomerulus showed a significant reduction in the TG pathway and collagen I and IV.Discussion: Our findings support a causal link between TG2 and tubulointerstitial fibrosis in rats following RWI. In contrast, the glomerular TG-pathway was suppressed, suggesting a protective mechanism in response to RWI, which may help to explain the lack of glomerular involvement in feline CKD. This rodent model of RWI may be analogous to feline CKD, enabling extrapolation of findings from rodent RWI models to understand renal insult in cats.
Keywords: Glomerular Transglutaminase, Tubulointerstitial Transglutaminase, feline chronic kidney disease, Renal warm ischemia, transglutaminase 2 (TG2)
Received: 31 Oct 2024; Accepted: 22 Apr 2025.
Copyright: © 2025 Sanchez Lara, Maamra and Haylor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Armando Cristian Sanchez Lara, Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, Cambridge, CB3 0ES, England, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.